企業プロフィール
4D Molecular Therapeutics, Inc. 株価・ニュース・カタリスト
- ティッカー:
- FDMT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
14.54 USD (+19.32%)
終値
最終更新: 2026年8月17日
485M USD
時価総額
株価変動の要因
Following the latest company update, “4DMT Announces New Employment Inducement Grants”, FDMT closed up 19.3% at $14.54 on Aug 17, 2026. The move occurred in the trading session associated with this company update.
企業概要
事業概要
4D Molecular Therapeutics is a gene-therapy company focused on precision engineered viral vectors and genetic medicine. Its story centers on using vector engineering to improve tissue targeting and therapeutic performance.
所在地とセクター分類
4DMT is headquartered in the United States and listed on NASDAQ. It sits in gene therapy and platform biotechnology.
ビジネスモデルの特徴
The company depends on platform validation, clinical progress, and the ability to convert vector engineering into clinically meaningful products. Investors follow data, safety, and strategic development milestones.
バイオ業界での位置付け
4D Molecular Therapeutics occupies a premium gene-therapy platform niche within biotech. The stock is catalyst-sensitive because the market is still proving how powerful its vector-engineering approach can be.
今後のカタリスト
- 4D Molecular Therapeutics's catalysts are 4D-150 and 4D-310, the gene-therapy programs the market will use to judge whether the platform is still gaining traction. Each data update matters because the story is still mostly about platform validation.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。